This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effect of Fetuin A in Hemodialysis Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2006 by University of Shizuoka.
Recruitment status was:  Active, not recruiting
Maruyama Memorial General Hospital
Information provided by:
University of Shizuoka Identifier:
First received: March 27, 2006
Last updated: May 18, 2006
Last verified: March 2006
The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

Hemodialysis Malnutrition

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective
Official Title: The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients

Resource links provided by NLM:

Further study details as provided by University of Shizuoka:

Estimated Enrollment: 300
Study Start Date: March 2001
Estimated Study Completion Date: March 2006
Detailed Description:
Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

Ages Eligible for Study:   up to 70 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Hemodialysis for at least 6 months

Exclusion Criteria:

  • Disabled patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00309426

Maruyama Hospital
Hamamatsu, Shizuoka, Japan, 430-0001
Sponsors and Collaborators
University of Shizuoka
Maruyama Memorial General Hospital
Study Chair: Hiromichi Kumagai, MD University of Shizuoka
  More Information Identifier: NCT00309426     History of Changes
Other Study ID Numbers: CT2006003
Study First Received: March 27, 2006
Last Updated: May 18, 2006

Keywords provided by University of Shizuoka:

Additional relevant MeSH terms:
Nutrition Disorders processed this record on August 21, 2017